Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.
View Top Employees from Deciphera PharmaceuticalsWebsite | http://www.deciphera.com |
Ticker | DCPH |
Revenue | $121.9 million |
Funding | $1 billion |
Employees | 417 (417 on RocketReach) |
Founded | 2003 |
Address | 200 Smith St, Waltham, Massachusetts 02451, US |
Phone | (781) 209-6400 |
Fax | (785) 830-2150 |
Technologies |
JavaScript,
HTML,
reCAPTCHA
+34 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Medical, Drug Discovery, Healthcare, Health Care, Other Pharmaceuticals and Biotechnology, Pharmaceutical, Therapeutics |
Web Rank | 3 Million |
Keywords | Biopharmaceuticals, Innovative Medicine, Cancer Treatment, Personalized Medical Care, Targeted Cancer Therapies |
Competitors | Clovis Oncology, G1 Therapeutics, Inc., Karyopharm Therapeutics Inc., Lengo Therapeutics, Mirati Therapeutics Inc |
SIC | SIC Code 283 Companies, SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325413 Companies, NAICS Code 32 Companies |
Looking for a particular Deciphera Pharmaceuticals employee's phone or email?
The Deciphera Pharmaceuticals annual revenue was $121.9 million in 2024.
417 people are employed at Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is based in Waltham, Massachusetts.
The NAICS codes for Deciphera Pharmaceuticals are [325, 3254, 32541, 325413, 32].
The SIC codes for Deciphera Pharmaceuticals are [283, 87, 28, 873].